Denne indikation er kun godkendt som indikation i nogle af medlemsstaterne, mens oplysningerne i andre kun er beskrevet under afsnit 5. 1 Farmakodynamiske egenskaber.
This indication was approved as an indication only in some Member States and in others the data are described only under section 5.1 Pharmacodynamic properties.